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Abstract
Environmental or genomic changes during evolution can relax negative selection pressure on specific loci, permitting high
frequency polymorphisms at previously conserved sites. Here, we jointly analyze population genomic and comparative
genomic data to search for functional processes showing relaxed negative selection specifically in the human lineage,
whereas remaining evolutionarily conserved in other mammals. Consistent with previous studies, we find that olfactory
receptor genes display such a signature of relaxation in humans. Intriguingly, proteasome genes also show a prominent
signal of human-specific relaxation: multiple proteasome subunits, including four members of the catalytic core particle,
contain high frequency nonsynonymous polymorphisms at sites conserved across mammals. Chimpanzee proteasome
genes do not display a similar trend. Human proteasome genes also bear no evidence of recent positive or balancing
selection. These results suggest human-specific relaxation of negative selection in proteasome subunits; the exact
biological causes, however, remain unknown.
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Negative or purifying selection is selection acting against new
deleterious mutations. A consequence of negative selection
is the removal of new deleterious genetic variants from the
population, resulting in evolutionary sequence conservation.
The intensity of negative selection, or “evolutionary con-
straint,” can vary across the genome according to functional
properties encoded by the respective loci (Dickerson 1971;
Sunyaev et al. 2000; Siepel et al. 2005). Repetitive intergenic
sequences far from coding regions likely evolve relatively freely
because evolutionary changes here will not affect the fitness
of the organism. By contrast, evolutionary changes in protein-
coding genes, especially those involved in essential cellular
functions, in development, or in the central nervous system,
can readily impact organismal function and fitness; the
evolution of such genes may be highly constrained. Such
constraint can be detected in actual genomic data, both
among and within species. For example, genes expressed
across multiple tissues and/or functioning in the neural
system have low nonsynonymous to synonymous mutation
rates among mammals (dN/dS) (Kuma et al. 1995; Duret and
Mouchiroud 2000; Mikkelsen et al. 2005; Nielsen et al. 2005).
Within humans, genic regions contain fewer polymorphism
than intergenic regions, and nonsynonymous single nucleo-
tide polymorphisms (nsSNPs) are maintained at lower fre-
quencies than synonymous SNPs (sSNPs) (Cargill et al.
1999; Sunyaev et al. 2000).
Levels of evolutionary constraint, reflected in genetic
sequence conservation, are generally correlated across related
species—the same genes and functions show high or low
constraint in hominids and rodents (Ohta 1993; Mikkelsen
et al. 2005). Still, exceptions can arise through multiple
mechanisms (Fay and Wu 2003). First, the strength of natural
selection is expected to be a function of effective population
size, such that lineages with relatively small population sizes
may experience weaker negative selection throughout the
genome. In populations experiencing reductions in popula-
tion size, slightly deleterious mutations which were originally
not tolerated may drift to high frequency, and even become
fixed (Ohta and Kimura 1971). For example, humans
and chimpanzees have higher genome-wide dN/dS levels
compared with rodents, possibly due to the smaller effective
population size in hominids allowing fixation of slightly
deleterious alleles (Wu and Li 1985; Li and Tanimura 1987;
Ohta 1993; Mikkelsen et al. 2005).
A decrease in negative selection pressure caused by
reduced effective population size should affect a large
number of genes across the genome. In turn, changes in a
species’ environment or in its genome can relax negative
selection on individual genes or classes of genes. One such
change is gene duplication, which could reduce negative se-
lection on the duplicated copies (Ohno 1972; Kondrashov
et al. 2002). Changes in environment and subsistence mode
can similarly cause relaxation of selection in specific genes.
The best-known example in humans is olfactory receptors
(Rouquier et al. 1998). This vast gene family appears under
relaxed selection in New World monkeys, Old World mon-
keys, and hominoids, as observed in the high rates of pseu-
dogenization and deletion of member genes; possibly due to a
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transition from nocturnal to diurnal activity in these lineages
(Gilad et al. 2003, 2004; Go and Niimura 2008; Kim et al. 2010;
Matsui et al. 2010) (positive selection on olfactory genes in
humans has also been reported [Williamson et al. 2007]). A
recent study on relaxation of constraint in the human
genome similarly found a high frequency of potentially dam-
aging nonsynonymous polymorphism among olfactory re-
ceptors (Pierron et al. 2012). Interestingly, mutations
causing color blindness are also common in humans, but
not in chimpanzees, for reasons yet unclear (Terao et al. 2005).
Studying human-specific changes at evolutionarily con-
served sites could provide insight into how the human species
has diverged from its relatives. A number of studies have
searched for conserved regions that have accumulated a
high number of fixed substitutions on the human lineage;
these are likely examples of adaptive evolution (Pollard,
Salama, King, et al. 2006; Pollard, Salama, Lambert, et al.
2006; Prabhakar et al. 2006). Other studies have identified
nonconserved regions under purifying selection in humans
(Ward and Kellis 2012), found relaxed negative selection in
recently evolved primate genes (Cai and Petrov 2010), and
shown relaxed constraints among human and nonhuman
primate olfactory genes using comparative genomic data
(Gilad et al. 2003; Go and Niimura 2008) and using human
polymorphism data (Pierron et al. 2012).
Here, we address the question of human-specific relaxation
of negative selection at coding sites, combining genome rese-
quencing data from humans, exome sequencing data from
chimpanzees, and comparative genomic data.
Results and Discussion
We tested for human-specific relaxation of constraint among
groups of functionally related genes using three criteria:
1) genes in a group should have low levels of mammalian
protein sequence divergence but relatively high human
nonsynonymous diversity, 2) that the group should have
higher human nonsynonymous diversity levels than the
genome average, 3) that the group should have low levels
of chimpanzee nonsynonymous diversity relative to human
diversity (fig. 1A).
We first catalogued over 64,000 nonsynonymous
and over 54,000 synonymous SNPs ascertained in 54 unre-
lated individuals of diverse ancestry in the Complete
Genomics genome-wide high coverage resequencing data
set (Drmanac et al. 2010) (supplementary material,
Supplementary Material online). The nonsynonymous
minor allele frequency (nsMAF) distribution was highly
skewed toward lower values relative to the synonymous
minor allele frequency (sMAF) distribution (supplementary
fig. S1A, Supplementary Material online), consistent with
the role of negative selection preventing nonsynonymous
mutations from reaching high frequency (Cargill et al.
1999). Median nsMAF values, calculated per gene, showed
modest but significant correlation with dN/dS values per
orthologous gene, calculated between mouse and macaque,
or dog and elephant (~ 0.20, one-sided Spearman correla-
tion test P< 1080, n> 10,000 genes) (supplementary fig. S1B
and C, Supplementary Material online). This correlation likely
reflects similar levels of negative selection between and within
species.
Using forward population genetic simulation (Hernandez
2008), we then tested whether 20 loci evolving under purely
neutral regimes could be identified among 1,000 loci evolving
under negative and positive selection (supplementary mate-
rial, Supplementary Material online). There was modest
(>40%) power to distinguish between neutral and negative
selection, which increased to more than 60% using 40 loci
(supplementary fig. S2, Supplementary Material online). We
also found that MAF is a somewhat more robust measure
for identifying neutrally evolving loci than derived allele
frequency (DAF) if the alternative hypothesis is a mixture
of positive and negative selection, as DAF is more strongly
affected by positive selection (supplementary fig. S2,
Supplementary Material online). These results suggest that
median nsMAF is a useful statistic for investigating hypothe-
ses regarding relaxation of constraints in the human genome.
Human nsMAF and mammalian dN/dS values showed
correlation when summarized in 181 KEGG pathways
(Kanehisa et al. 2008) (fig. 1B). Only a few functional groups
stood out, with higher median nsMAF, despite low median
dN/dS. These included not only various metabolic pathways,
such as propanoate metabolism and glycosaminoglycan deg-
radation, but also olfactory transduction, and the proteasome
(supplementary table S1, Supplementary Material online). We
then tested whether genes in a functional group have the
same median ranks with respect to dN/dS, relative to their
ranks with respect to nsMAF (fig. 1A and C) (Wilcoxon signed
rank test). We further tested whether a gene set has the same
median rank of nsMAF values compared with other genes
(Wilcoxon rank sum test). Only two KEGG groups showed
higher than expected polymorphism in both tests: olfactory
transduction and the proteasome (Benjamini-Hochberg cor-
rected P< 0.05, supplementary table S1, Supplementary
Material online). Among the 373 genes in the olfactory trans-
duction pathway, 323 contained at least one nsSNP (median
nsMAF = 0.029). Among the 44 genes annotated within
the proteasome category, 18 contained nsSNPs (median
nsMAF = 0.044), 12 of these with modest to high fre-
quency (>5%) alleles among both African and non-African
individuals (fig. 1D). A randomization test across genes con-
firmed that nsMAF values in both groups are significantly
skewed compared with other genes with nsSNPs
(P< 0.0001; note that the olfactory receptors are found
in clusters, which is ignored in this test; proteasome genes,
however, tend to reside on different chromosomes and are
not clustered).
We then asked whether these putative shifts in negative
selection pressure can also be observed in our closest living
relatives, the chimpanzees, or whether they might be human
specific. For this, we used a published exome resequencing
data set containing close to 25,000 nonsynonymous and
32,000 synonymous SNPs ascertained in 12 central chimpan-
zees, Pan troglodytes troglodytes (Hvilsom et al. 2012) (supple-
mentary material, Supplementary Material online). Examining
KEGG pathways for a difference in human nsMAF ranks
relative to chimpanzee nsMAF ranks, we found olfactory
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transduction and proteasome genes were among the top
eight pathways exhibiting the most significant differences
across 181 pathways (nominal Wilcoxon signed rank test
P< 0.05; although the proteasome gene set was not signifi-
cant after multiple testing correction) (fig. 1E; supplementary
table S1, Supplementary Material online). By randomizing
genes across KEGG groups and repeating the three tests
(i.e., comparing human nsMAF in each KEGG group with
the genome average, comparing nsMAF per group with
dN/dS, and with chimpanzee nsMAF) 10,000 times, we
determined that finding two groups with significant results
in all tests was unlikely (P= 0.0015).
We repeated the analysis using the mean instead of
median nsMAF per gene, as well as the proportion of
FIG. 1. (A) Representation depicting the tests for human-specific relaxed selection. Genes in a gene set are ranked according to functional human
diversity (nsMAF), mammalian divergence (dN/dS), or chimpanzee diversity (nsMAF). The ranks are compared using a Wilcoxon signed rank test
(supplementary material, Supplementary Material online). (B) Median human nsMAF and mouse–rhesus macaque dN/dS values among 181 KEGG
pathways, each containing minimum five genes. Each dot represents one KEGG gene set. Groups that have significantly higher human diversity ranks
relative to mammalian divergence ranks (as in A, Wilcoxon signed rank test), and also have significantly higher human diversity in member genes
compared with the genome average (Wilcoxon rank sum test), are indicated in red. (C) Genes (n= 12,405) were ranked according to their relative
mouse–rhesus macaque dN/dS (right) or human nsMAF (left) values, with higher ranks indicating weaker negative selection. Each line represents a gene
and connects its dN/dS and nsMAF-based ranks. The red lines show proteasome and green lines show selenoamino acid metabolism genes. The two
groups were chosen as examples representing significant shifts or no shifts toward human–specific relaxation, respectively. (D) nsMAF values at
common proteasome nsSNPs (world-wide MAF> 0.05) in Africans and non-Africans. nsMAF in the non-African sample is higher, but not significantly
(Wilcoxon signed rank test P= 0.2). (E) Median human nsMAF and chimpanzee nsMAF values among 182 KEGG pathways with minimum give genes,
shown as in (A).
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common (>5% MAF) nonsynonymous SNPs per gene. Again,
olfactory transduction and proteasome groups had significant
results in all three tests (supplementary fig. S3A–D and
table S2, Supplementary Material online). Next, we used the
phase I version of the 1000 genomes data set, which con-
tains a substantially larger set of individuals, although repre-
senting a smaller subset of worldwide human genetic
variation (1000 Genomes Project Consortium 2012).
Because our analyses focus on common polymorphism,
we only included SNPs at MAF more than 0.005 in this
data set (~54,000 nsSNPs). Olfactory transduction and
proteasome genes again showed a trend of higher human
polymorphism relative to mammalian divergence or to chim-
panzee polymorphism (although this trend was not sta-
tistically significant using mean nsMAF) (supplementary
fig. S3F–H, Supplementary Material online).
A closer examination of the chimpanzee polymorphism
at olfactory transduction-related genes revealed that these
genes also had higher-than-average nsMAF in chimpanzees
(fig. 2A and B). Relaxed negative selection on olfactory genes
may therefore be a shared trend between humans and chim-
panzees, albeit more pronounced in humans. This is consis-
tent with the tendency of the olfactory receptor family
toward pseudogenization in primates, likely reflecting de-
creased reliance on olfactory perception in this lineage
(Gilad et al. 2003, 2004; Kim et al. 2010; Matsui et al. 2010;
Pierron et al. 2012), as well as positive or balancing selection
(Williamson et al. 2007).
In contrast, there is no indication of higher nsMAF values
among chimpanzee proteasome genes (fig. 2D), despite what
was observed in humans (fig. 2C). Our chimpanzee data are
limited to only 12 individuals and therefore the variability
in chimpanzee MAF estimates are high. Nevertheless, we
find no evidence of relaxation of selection in chimpanzees.
For example, the nsMAF spectrum in chimpanzee Wnt sig-
naling pathway genes, which regulate major developmental
processes and are thus expected to remain under strong
negative selection in both humans and chimpanzees, is com-
parable with the distribution of nsMAF in chimpanzee
proteasome genes (fig. 2D and F). This provides another
FIG. 2. Distribution of median MAF for nsSNPs and sSNPs in human (left panels) and chimpanzee (right panels), across genes in three KEGG pathways:
olfactory transduction (n= 323), proteasome (n= 18), and Wnt signaling (n= 87), compared with the all genes annotated in KEGG and with nsSNPs in
human and chimpanzee data sets (n= 3,741). Wnt signaling was chosen here as an example category that is expected to be under strong negative
selection in both human and chimpanzee. The left and right y axes show the percentage of genes falling in a MAF quantile across all genes or genes in a
KEGG pathway, respectively. We use the same subset of genes with SNPs detected in both human and chimpanzee. Note that the chimpanzee site
frequency spectrum is less skewed to the left than that of human, due to the fact that we use 12 chimpanzee and 54 human subjects. The asterisks show
significance measured in a two-sided Wilcoxon rank sum test. P< 0.10; **P< 0.01; ***P< 0.001.
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line of evidence that the proteasome genes are likely evolving
under negative selection in chimpanzees.
Indeed, like the spliceosome, the proteasome is a major
component of eukaryotic cells. This is the key machinery for
degrading proteins marked by ubiquitin, which can be dam-
aged or misfolded proteins, signaling proteins involved in cell
cycle and apoptosis, or antigens (Driscoll and Goldberg 1990;
Richter-Ruoff and Wolf 1993; Chondrogianni et al. 2003; see
Ciechanover 2005 and Tanaka 2009 for reviews). The main
structure contains a 20S catalytic core, consisting of two
sets of seven alpha and seven beta subunits, and two sets
of 19S regulatory particles, containing 18 distinct subunits
each (fig. 3A and B). Each subunit is coded by one gene.
Combined with additional peptides, these structures can
further give rise to the immunoproteasome or the thymopro-
teasome (Tanaka 2009). Notably, among proteasome subu-
nits, those with nsSNPs have slightly higher dN/dS levels
relative to those without nsSNPs (supplementary fig. S4,
Supplementary Material online). Still, all proteasome
gene sets have significantly lower mammalian dN/dS values
compared with the rest of the genome, indicating strong
conservation (Wilcoxon rank sum test P< 0.05).
Because high frequency coding polymorphism among a
conserved gene set is unexpected, we asked whether the
proteasome SNPs, or their high allele frequencies, may be
caused by artifacts relating to the computational processing
of the data. To do this, we first compared the frequencies of
the 12 common (>5% nsMAF) proteasome SNPs identified
in the Complete Genomics data set, with nsMAF calculated
from the phase I version of the 1000 genomes data set (1000
Genomes Project Consortium 2012) (supplementary mate-
rial, Supplementary Material online). This revealed high
consistency between data sets in comparisons with 14 pop-
ulations (0.38<< 0.95, P< 0.05 in 11 comparisons)
(supplementary fig. S5, Supplementary Material online).
However, because the samples included in the two data
sets overlap, we used a second, independent exome sequenc-
ing data set of 200 Danish individuals (Li et al. 2010)
(supplementary material, Supplementary Material online).
Importantly, this data set is derived from primary tissue
FIG. 3. (A) Schematic representation of the proteasome 20S core and 19S regulatory particles based on (Tanaka 2009). Peptides are colored with respect
to their polymorphism characteristics. Note that the b1 subunit coded by PSMB6 contains a SNP that is close to fixation in humans, with derived allele
frequency (DAF) = 0.98. (B) Representation of bovine 20S core complex, with nsSNP containing chains shown in orange. (C) Box plot showing the
percentage of number of nonsynonymous mutations per nonsynonymous site among proteasome genes compared with all genes with at least one
mutation (n= 17,294) in the Complete Genomics data set. We assign zero to any gene where only synonymous SNPs are detected (n= 2,191). Note that
among 33 proteasome genes, 15 contain only sSNPs but no nsSNP. Outliers are not shown. ***P< 0.001.
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instead of cell lines, which also allows us the potential to
exclude in vitro proteasome mutations. Ten proteasome
nsSNPs from the Complete Genomics data set were detected
in the Danish data set. All 10 had MAF> 0.05 in both data
sets and the allele frequencies across the SNPs were highly
correlated (= 0.71, P< 0.02) (supplementary fig. S6A,
Supplementary Material online). We then asked whether
high allele frequencies may be influenced by copy number
variation. Using sequencing depth in the Danish data set as
proxy for copy number, we found no indication that protea-
some sites had higher sequencing depth than other sites
(supplementary fig. S6B and C, Supplementary Material
online). Known paralogs are not likely to cause the signal,
as human proteasome genes have no close paralogs, and
proteasome genes with and without distant paralogs
showed no difference in nsMAF (supplementary fig. S6D,
Supplementary Material online). Also, we find no indication
for higher synonymous polymorphism among proteasome
genes (supplementary fig. S7, Supplementary Material
online). Furthermore, we used a stringent cutoff for Hardy–
Weinberg equilibrium testing to filter out SNPs with an excess
of heterozygotes that could also be caused by paralogs (sup-
plementary material, Supplementary Material online). In
conclusion, the pattern of high frequency nonsynonymous
polymorphisms in human proteasome genes is replicable
between data sets and is unlikely to be artifactual.
We then considered the possibility that the identified high
frequency proteasome nsSNPs may be affecting the least
functional parts of the respective proteins. We thus
tested whether sites with common proteasome nsSNPs
(MAF> 0.05) show conservation across mammals. Six pro-
teasome nsSNPs could be aligned to 13 high-quality mamma-
lian genomes, and we found no substitutions among these
species at these sites (supplementary material, Supplementary
Material online). In contrast, in 39% of common nsSNPs in
other genes we find at least one substitution (one-sided
binomial test P= 0.051). These results imply that some of
the proteasome subunit sites bearing common nonsynony-
mous polymorphism in humans are not evolving neutrally in
other mammals, and may have functional effects.
We then examined the potential functional role of
common proteasome nsSNP alleles. With respect to physio-
logical function, no genome-wide disease association has
been reported for the common proteasome SNPs. With
respect to protein structure, PolyPhen (v2) (Adzhubei et al.
2010) predicted one of the 12 common mutations as
“possibly-damaging,” and SIFT (Kumar et al. 2009) predicted
two as “deleterious” (supplementary table S3, Supplementary
Material online). These were in the PSMB3 and PSMB4 genes,
encoding subunits of the 20S proteasome core complex
(fig. 3A). The PSMB4 mutation is within putative conserved
domains according to BLASTP, and the PSMB3 mutation is
within an active site of the protein. Taken together with the
conservation tendency across mammals, this information
suggests that some proteasome gene-related SNPs in
humans may affect functional sites.
Intriguingly, only about one-half of proteasome genes as
annotated in KEGG (n= 18) carry nsSNPs in the Complete
Genomics data set; the others (n= 15) only contain synony-
mous SNPs. This is significantly higher than the genome
average (expected = 13%, observed = 45%, hypergeometric
test P< 0.001). Likewise, the median density of nonsynony-
mous mutations per nonsynonymous site is five times lower
among proteasome genes than the genome average
(Wilcoxon rank sum test P< 0.001) (fig. 3C). Surveying the
distribution of the peptides coded by nsSNP-bearing genes
within the proteasome complex, we further noticed a peculiar
pattern: within the 20S catalytic core, only beta subunits
carried human nsSNPs, with four genes with common
nsSNPs (fig. 3A and B). Yet another beta subunit, PSMB6,
also carries a high frequency (>95%) derived nsSNP. In con-
trast, the seven alpha subunits only contained sSNPs.
Thus, the human proteasome, as a whole, appears under
negative selection, despite common nsSNPs in one layer of
its catalytic core.
What could allow nonsynonymous mutations in the
core human proteasome to reach such high frequencies?
A number of scenarios are conceivable: balancing selection
specific to humans, ongoing positive selection, compensatory
mutations following a fixation event in humans, or relaxed
constraints. Given the multiple roles of this complex,
including immune response, stress response, and aging
(Chondrogianni et al. 2003; reviewed in Ciechanover 2005;
Tanaka 2009), positive or balancing selection on proteasome
genes, due to human-specific changes in longevity or immune
response is not implausible. To identify any signature of past
or ongoing selection, we first surveyed human-chimpanzee
differences in core proteasome genes. Aligning human, chim-
panzee, and rhesus macaque beta subunit protein sequences
revealed no human-specific substitution, only two high-
frequency derived SNPs. Thus, these genes do not show
evidence for adaptive change in their coding sequences
in the human lineage. Proteasome genes also showed no
indication of recent positive selection in European–
American or in Yoruban individuals (supplementary fig. S8,
Supplementary Material online), either as high haplotype
homozygosity measured by iHS (Voight et al. 2006), or as
extremely low or high Tajima’s D values indicating an
excess of rare alleles or an excess of intermediate alleles,
respectively (Tajima 1989). Neither did proteasome genes
have high scores in a recently developed composite likeli-
hood-based statistic for balancing selection (DeGiorgio M,
Lohmueller KE, Nielsen R, in review). In fact, while proteasome
genes had negative Tajima’s D values consistent with negative
selection and/or human population growth, those protea-
some subunits carrying common nsSNPs tended to have
Tajima’s D values closer to zero than other proteasome
genes, implying weaker negative selection. Notably,
common nsMAF (>5%) SNPs do not show conspicuous dif-
ferentiation between African and non-African populations
(fig. 1D). We also find four common proteasome nsSNPs
in the Denisovan genome (Meyer et al. 2012) (supplementary
table S3, Supplementary Material online), which suggests that
a possible shift in selection pressure appeared at least 800,000
years ago. Finally, using a primate gene expression data set
including different tissues (Brawand et al. 2011), we found no
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consistent differentiation in gene expression between
humans and chimpanzees among nsSNP containing protea-
some genes (data not shown).
To summarize, our genome-wide scan for human-specific
relaxation of constraint identified two candidate functions:
olfactory transduction and proteasomal degradation. The
former is well-studied, but the latter is novel and unexpected.
Our results do not imply an overall relaxation of constraint
among proteasome subunits; rather, common nonsynony-
mous SNPs appear clustered in the complex, and include
sites under constraint in other mammals. The trend appears
specific to the hominin lineage. Still, given the small sample
size of the chimpanzee data set used here, nonsynonymous
polymorphism in proteasome genes require further investi-
gation among great apes.
The reason for high frequency nonsynonymous polymor-
phism in human proteasome genes remains unclear. We find
no indication for positive or balancing selection on the genes
in question. One possibility is that a general trend of relaxa-
tion of constraint in humans (Wu and Li 1985; Ohta 1993;
Mikkelsen et al. 2005; Kosiol et al. 2008) affected these previ-
ously conserved sites by chance, although the significant GO
classification makes this explanation unlikely. Alternatively,
one may speculate that changes in human evolution that
affected functions regulated by the proteasome–ubiquitin
pathway, such as increased longevity (Li and de Magalha˜es
2011), or increased intake of dietary protein (Finch and
Stanford 2004; Babbitt et al. 2011), may have altered selective
pressure on particular proteasome subunits. For example,
the ubiquitin–proteasome system is a major contributor
of protein turnover in muscle, which is directly affected by
essential amino acid intake (Tawa et al. 1992; Wakshlag et al.
2003; Combaret et al. 2005). All known human diets are more
protein rich than that of chimpanzees (Finch and Stanford
2004). It is thus conceivable that increased consumption of
essential amino acids reduced selection pressure on the
human proteasome’s efficacy for maintaining protein turn-
over, allowing for slightly deleterious mutations at previously
conserved sites. More studies of the functional effects of
common proteasome mutations humans may help to clarify
this enigmatic point in the future.
Supplementary Material
Supplementary figures S1–S8 and tables S1–S3 are available at
Molecular Biology and Evolution online (http://www.mbe.
oxfordjournals.org/).
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